Doctors confident Yuvraj won't suffer cancer relapse

NEW DELHI Mon Apr 9, 2012 11:25pm IST

Cricketer Yuvraj Singh (wearing red cap) arrives at the Indira Gandhi International Airport in New Delhi April 9, 2012. REUTERS/Adnan Abidi

Cricketer Yuvraj Singh (wearing red cap) arrives at the Indira Gandhi International Airport in New Delhi April 9, 2012.

Credit: Reuters/Adnan Abidi

Related Topics

NEW DELHI (Reuters) - Yuvraj Singh has arrived home in India after cancer treatment in United States and doctors are confident the player will not suffer a relapse, the Board of Control for Cricket in India (BCCI) said on Monday.

The 30-year-old was told last year that he had a golf ball-sized non-malignant tumour but that diagnosis was changed in February to a cancerous condition called "mediastinal seminoma".

"After finishing his treatment (in the U.S.) in mid-March, Yuvraj spent a few days in London recuperating from the side-effects of chemotherapy," the BCCI said on its website (www.bcci.tv).

"Yuvraj's doctors were happy with his reaction to the treatment and were confident he wouldn't suffer a relapse."

One of the cleanest strikers of a cricket ball, the middle-order batsman is not a regular member of India's test team but is an automatic choice in their limited-over sides.

Yuvraj was instrumental in India's 2007 World Twenty20 title triumph in South Africa and hit England fast bowler Stuart Broad for six sixes in an over in one match.

He was also named player of the tournament in India's successful 50-over World Cup campaign on home soil last year.

(Writing by Tony Jimenez in London, editing by Dave Thompson)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Sino-Indian Ties

REUTERS SHOWCASE

India-China Relations

India-China Relations

India and China look to put knotty relations on new footing.  Full Article 

Importing Iron Ore

Importing Iron Ore

As mining curbs bite, India offers market to glut-hit iron ore.  Full Article 

Lower Output

Lower Output

IOC cuts refinery output as rains hit fuel demand - source.  Full Article 

Drug Approval

Drug Approval

Epirus, Ranbaxy win India approval for arthritis drug copy.  Full Article 

Farming and Technology

Farming and Technology

Climate smart farmers get tech savvy to save India's bread basket.  Full Article 

Rajan Speaks

Rajan Speaks

RBI chief Rajan says limiting reliance on foreign debt.  Full Article 

India-Vietnam Ties

India-Vietnam Ties

India tightens Vietnam defence, oil ties ahead of China Xi's visit.  Full Article 

Debt & Equity Deal

Debt & Equity Deal

KKR to lend $175 million to GMR Infrastructure - source.  Full Article 

Preparing for IPO

Preparing for IPO

Alibaba boosts IPO as demand strengthens.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage